News and Updates

The FDA authorized the Insulet Omnipod 5, the world’s first tubeless, wearable system, for children 2+, using an algorithm that began by Breakthrough T1D funding.

The name Jambo might not be familiar to you, but to more than 22,000 Twitch users and 38,000 Twitter followers, she’s a gaming influencer.

Congratulations to Dr. Albanese-O'Neill, director of screening and clinical trials, who was honored with the Diabetes Care and Education Specialist of the Year Award!

Breakthrough T1D-funded researchers in Colorado and Germany found no link between COVID-19 and type 1 diabetes in children and adolescents ages 1-18.

Congress passes the Inflation Reduction Act, which contains provisions that will make insulin affordable for some Americans. Much more must be done.

Misdiagnosing adults with type 1 diabetes (T1D) is an all-too-common problem that can have tragic consequences. Breakthrough T1D and IQVIA partnered up to tackle it—and the results were just published.

Breakthrough T1D Urges Senate to Support Insulin Affordability Provisions as Part of Inflation Reduction Act of 2022

Learn more about the recipients of the International Society for Pediatrics and Adolescent Diabetes (ISPAD)-Breakthrough T1D Fellowships here!

California Governor Gavin Newsome announced plans for the state to manufacture and distribute its own insulin.

Longtime volunteer Jennifer Bennett has been appointed Chair of the Breakthrough T1D Global Mission Board, effective July 1, 2022.